Do you want to link to this Amgen Site outside the UK and leave

YOU ARE NOW LEAVING THIS WEBSITE. Amgen Limited and Amgen Ireland Limited takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Please specify your location:

Do you want to link to this External Site and leave

YOU ARE NOW LEAVING THIS WEBSITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Patient Advocacy Group Funding

2023 | 2022 | 2021 | 2020 | 2019

Amgen partners with patient advocacy groups for the benefit of patients and in a way that is true to the Industry Codes of Practice and Amgen's policy. Amgen is committed to making public the scope of its partnerships in the UK & Ireland in order to increase transparency. This includes stating the amount of funding that Amgen provides each year.

For the purposes of transparency and clarity, the following declarations include grants, donations and sponsorships provided by Amgen Limited (UK), Amgen Ireland Limited, and grants, donations and sponsorships made by Amgen Inc. (USA) to patient advocacy organisations based in the UK and Ireland.

In 2023, Amgen Ltd (UK) made the following payments:

Arthritis Action

Arthritis Action is the UK charity offering an integrated self-management approach, to help address the physical and mental health symptoms of living with arthritis.

In 2023, Amgen Ltd (UK) Provided a grant of £5,000 to enable the provision of support and information for patients impacted by arthritis, including support for young adults; raising awareness of the signs and symptoms of arthritis to increase understanding and diagnosis of the condition.

Bowel Cancer UK

The UK’s leading bowel cancer charity, Bowel Cancer UK are determined to save lives and improve the quality of life of everyone affected by bowel cancer by championing early diagnosis and access to best treatment and care. They support and fund targeted research, provide expert information and support to patients and their families, educate the public and professionals about the disease, and campaign for early diagnosis and access to best treatment and care.

In 2023, Amgen Ltd (UK) provided a grant of £5,000 to support Bowel Cancer UK’s Healthcare Professional Events programme between September and October 2022. This included supporting their virtual National Colorectal Cancer Nurse Network Education Event in September and funding one bite-sized learning module.

HEART UK – The Cholesterol Charity

HEART UK is the UK’s only cholesterol charity, providing support, information and influencing services for families and health professionals. Their vision is to prevent early disease and deaths from cholesterol and other blood fat (lipid) conditions in the UK. Their aim is for people to know and understand their cholesterol and other blood fat (lipid) levels and take appropriate action.

In 2023, Amgen Ltd (UK) provided sponsorship of £31,752 for membership of HEART UK’s CVD Collaborative Group and £12,500 for the LP(a) Taskforce; a proactive grant of £1,000 for their contributions to an Amgen internal educational event plus an honorarium of £1,165.65 for their attendance at that event. Sponsorship of £20,000 was paid for an exhibition stand, conference attendance and a symposia session at the Charity’s Annual Conference. In addition honoraria and expenses were paid for their participation in an interview for website content (£345), for them to speak at the HealthPlus Care Conference (£432.05) and their attendance at and contribution to the development of a policy event at Holyrood (£3,352.61).

ITP Support Association

The ITP Support Association is a UK registered charity which aims to promote and improve the general welfare of patients, and the families of patients with immune (idiopathic) thrombocytopenic purpura (ITP).

In 2023, Amgen Ltd (UK) provided sponsorship of £13,000 in support of the Annual ITP Patients Convention, the aim of which is to provide awareness and education to help manage ITP and improve quality of life for those with ITP.

Leukaemia Care

Leukaemia Care is the UK’s leading leukaemia charity. For over 50 years, they have been dedicated to ensuring that everyone affected receives the best possible diagnosis, information, advice, treatment and support.

In 2023, Amgen Ltd (UK) provided a grant of £5,000 to support the charity’s core activities, including improving the accessibility of their information sources; working on holistic and lifestyle support such as diet and nutrition; and expanding their hospital hubs that strengthen the clinical and community support provided to leukaemia patients.

Myeloma UK

Myeloma UK is the only organisation in the UK dealing exclusively with myeloma. The charity is dedicated to myeloma patients – making sure they get access to the right treatment at the right time. It strives to improve standards of treatment and care through research, education and raising awareness of myeloma.

In 2023, Amgen Ltd (UK) supported Myeloma UK with a grant of £20,000 to fund their Infoline and Ask the Nurse services, which provide vital access to information needed for patients and those around them to make sense of a myeloma diagnosis and to make informed decisions about treatment and care.

National Rheumatoid Arthritis Society (NRAS)

The National Rheumatoid Arthritis Society (NRAS), is the only patient-led organisation in the UK specialising in rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA). Due to its targeted focus on RA and JIA, NRAS provides truly expert and wide-ranging services to support, educate and campaign for people living with these complex autoimmune conditions, their families and the health professionals who treat them.

In 2023, Amgen Ltd (UK) provided sponsorship of £12,000 towards corporate membership of NRAS.

The Royal Osteoporosis Society

The Royal Osteoporosis Society (ROS) is the UK’s largest national charity dedicated to improving bone health and beating osteoporosis.

In 2023, Amgen Limited (UK) provided sponsorship of £25,000 for a stand, conference and exhibitor passes and a 60 minute symposium slot at the Royal Osteoporosis Society 2023 Conference plus £1,794 for filming of the Amgen symposium at the conference.

In 2023, Amgen Ireland Ltd made the following donation and sponsorship payments:

Patient Organisation Name Country Type(s) of support or services provided Description of the support or services provided Monetary value of financial support and/or invoiced costs Non-monetary benefit Fees for services paid
CROÍ, WEST OF IRELAND CARDIAC FOUNDATION Ireland Financial Support Honoraria for Croí representatives to participate in Amgen Staff Meeting at ADL in October 2023 2,686.00 EUR
DÓCHAS OFFALY CANCER SUPPORT GROUP Ireland Financial Support Sponsorship of Dóchas Offaly Cancer Support Group Wellness Day 2023 900.00
IRISH CANCER SOCIETY Ireland Financial Support Matching donation for fundraising event for Breast Cancer month by Women's Network 1,266.00 EUR
IRISH HEART FOUNDATION Ireland Financial support Charity walk by staff for Amgen Mission Week 2022 1,550.00 EUR
IRISH HEART FOUNDATION Ireland Financial support Honoraria to Irish Heart Foundation representative to speak at Amgen Staff Meeting at ADL in October 2023 574.00 EUR
IRISH OSTEOPOROSIS COMPANY LTD Ireland Financial Support Sponsorship of The Irish Osteoporosis Society Annual Medical Conference in October 2023 15,000.00 EUR
IRISH OSTEOPOROSIS COMPANY LTD Ireland Financial Support Donation towards the update and maintenance of the Irish Osteoporosis Society Charity Website in 2023 30,000.00 EUR
IRISH PLATFORM FOR PATIENTS' ORGANISATIONS, SCIENCE AND INDUSTRY Ireland Financial support Membership fee for The Irish Platform for Patient Organisations, Science and Industry (IPPOSI) 8,500.00 EUR
IRISH SKIN FOUNDATION Ireland Financial support Donation to the Irish Skin Foundation to support the operation and running costs for their nurse run Helpline which provides specialist guidance for people living with a skin condition in Ireland 20,000.00 EUR
LOOK GOOD FEEL BETTER IRELAND Ireland Financial Support Honorarium paid to the Look Good Feel Better organisation for their representative presenting at the Amgen organised National Oncology Nurses Meeting 2023 225.00 EUR
MULTIPLE MYELOMA IRELAND Ireland Financial Support Sponsorship of Multiple Myeloma Ireland Annual Wild Myeloma Way Cycle to raise funds and build awareness and advocacy for Multiple Myeloma in Ireland and support patients, their families and care givers. 7,500.00 EUR

In 2023, Amgen Inc. (USA) supported two international patient advocacy activities based in the UK. These are:

Roy Castle Lung Cancer Foundation

Roy Castle Lung Cancer Foundation is the leading UK lung cancer charity dedicated to helping everyone affected by the disease. They support everyone affected by lung cancer – from diagnosis, through treatment, living with the disease and end of life care.

In 2023, Amgen Inc. (USA) provided sponsorship of £30,000 for support of the Global Lung Cancer Coalition (GLCC) in 2024.

World Child Cancer UK

World Child Cancer is the leading international children’s charity dedicated to addressing the global inequality in childhood cancer care.

In 2023, Amgen Inc. (USA) provided sponsorship, with the first payment of $490,000, towards a collaboration project with World Child Cancer that will focus on improving early detection and access to treatment, strengthening paediatric oncology services for children with Burkitt lymphoma (BL) and delivering advocacy and sharing of learning for long-term impact. Amgen will provide funds towards the cost of running this project over 5 years (2023 - 2028).

All monies are shown in the currency paid. The reported figure to the Association of British Pharmaceutical Industry (ABPI) is in sterling (GBP).